Copyright © 2012 Jack Rosner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. V. W. Lin, C. M. Bono, D. D. Cardenas, et al., “Epidemiology of spinal cord injury,” in Spinal Cord Medicine: Principles and Practice, chapter 4, Demos Medical, LLC, 2010.
2. L. H. S. Sekhon and M. G. Fehlings, “Epidemiology, demographics, and pathophysiology of acute spinal cord injury,” Spine, vol. 26, no. 24, pp. S2–S12, 2001. View at Scopus
3. D. J. Strauss, M. J. DeVivo, D. R. Paculdo, and R. M. Shavelle, “Trends in life expectancy after spinal cord injury,” Archives of Physical Medicine and Rehabilitation, vol. 87, no. 8, pp. 1079–1085, 2006. View at Publisher · View at Google Scholar · View at Scopus
4. A. Blesch and M. H. Tuszynski, “Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination,” Journal of Comparative Neurology, vol. 467, no. 3, pp. 403–417, 2003. View at Publisher · View at Google Scholar · View at Scopus
5. J. W. Fawcett, A. Curt, J. D. Steeves et al., “Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials,” Spinal Cord, vol. 45, no. 3, pp. 190–205, 2007. View at Publisher · View at Google Scholar · View at Scopus
6. D. D. Cardenas, J. M. Hoffman, S. Kirshblum, and W. McKinley, “Etiology and incidence of rehospitalization after traumatic spinal cord injury: a multicenter analysis,” Archives of Physical Medicine and Rehabilitation, vol. 85, no. 11, pp. 1757–1763, 2004. View at Publisher · View at Google Scholar · View at Scopus
7. J. W. McDonald and C. Sadowsky, “Spinal-cord injury,” The Lancet, vol. 359, no. 9304, pp. 417–425, 2002. View at Publisher · View at Google Scholar · View at Scopus
8. V. R. Edgerton, S. J. Kim, R. M. Ichiyama, Y. P. Gerasimenko, and R. R. Roy, “Rehabilitative therapies after spinal cord injury,” Journal of Neurotrauma, vol. 23, no. 3-4, pp. 560–570, 2006. View at Publisher · View at Google Scholar · View at Scopus
9. M. B. Bracken, M. J. Shepard, W. F. Collins et al., “A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study,” The New England Journal of Medicine, vol. 322, no. 20, pp. 1405–1411, 1990. View at Scopus
10. M. B. Bracken, M. J. Shepard, T. R. Holford et al., “Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury: results of the Third National Acute Spinal Cord Injury randomized controlled trial,” Journal of the American Medical Association, vol. 277, no. 20, pp. 1597–1604, 1997. View at Scopus
11. R. J. Hurlbert, “Methylprednisolone for acute spinal cord injury an inappropriate standard of care,” Journal of Neurosurgery, vol. 93, no. 1, pp. 1–7, 2000. View at Scopus
12. F. T. Sayer, E. Kronvall, and O. G. Nilsson, “Methylprednisolone treatment in acute spinal cord injury: the myth challenged through a structured analysis of published literature,” Spine Journal, vol. 6, no. 3, pp. 335–343, 2006. View at Publisher · View at Google Scholar · View at Scopus
13. D. J. Short, W. S. El Masry, and P. W. Jones, “High dose methylprednisolone in the management of acute spinal cord injury—a systematic review from a clinical perspective,” Spinal Cord, vol. 38, no. 5, pp. 273–286, 2000. View at Scopus
14. I. Rozet, “Methylprednisolone in acute spinal cord injury: is there any other ethical choice?” Journal of Neurosurgical Anesthesiology, vol. 20, no. 2, pp. 137–139, 2008. View at Publisher · View at Google Scholar · View at Scopus
15. J. Lu, F. Féron, S. M. Ho, A. Mackay-Sim, and P. M. E. Waite, “Transplantation of nasal olfactory tissue promotes partial recovery in paraplegic adult rats,” Brain Research, vol. 889, no. 1-2, pp. 344–357, 2001. View at Publisher · View at Google Scholar · View at Scopus
16. S. Thuret, L. D. F. Moon, and F. H. Gage, “Therapeutic interventions after spinal cord injury,” Nature Reviews Neuroscience, vol. 7, no. 8, pp. 628–643, 2006. View at Publisher · View at Google Scholar · View at Scopus
17. M. D. Norenberg, J. Smith, and A. Marcillo, “The pathology of human spinal cord injury: defining the problems,” Journal of Neurotrauma, vol. 21, no. 4, pp. 429–440, 2004. View at Publisher · View at Google Scholar · View at Scopus
18. C. H. Tator and I. Koyanagi, “Vascular mechanisms in the pathophysiology of human spinal cord injury,” Journal of Neurosurgery, vol. 86, no. 3, pp. 483–492, 1997. View at Scopus
19. Y. Jiang, B. N. Jahagirdar, R. L. Reinhardt et al., “Pluripotency of mesenchymal stem cells derived from adult marrow,” Nature, vol. 418, no. 6893, pp. 41–49, 2002. View at Publisher · View at Google Scholar · View at Scopus
20. E. Park, A. A. Velumian, and M. G. Fehlings, “The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration,” Journal of Neurotrauma, vol. 21, no. 6, pp. 754–774, 2004. View at Publisher · View at Google Scholar · View at Scopus
21. M. J. Crowe, J. C. Bresnahan, S. L. Shuman, J. N. Masters, and M. S. Beattie, “Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys,” Nature Medicine, vol. 3, pp. 73–76, 1997.
22. E. Emery, P. Aldana, M. B. Bunge et al., “Apoptosis after traumatic human spinal cord injury,” Journal of Neurosurgery, vol. 89, no. 6, pp. 911–920, 1998. View at Scopus
23. W. I. Mcdonald and T. A. Sears, “The effects of experimental demyelination on conduction in the central nervous system,” Brain, vol. 93, no. 3, pp. 583–598, 1970. View at Publisher · View at Google Scholar · View at Scopus
24. J. L. Becerra, W. R. Puckett, E. D. Hiester et al., “MR-pathologic comparisons of wallerian degeneration in spinal cord injury,” American Journal of Neuroradiology, vol. 16, no. 1, pp. 125–133, 1995. View at Scopus
25. A. Buss, K. Pech, D. Merkler et al., “Sequential loss of myelin proteins during Wallerian degeneration in the human spinal cord,” Brain, vol. 128, no. 2, pp. 356–364, 2005. View at Publisher · View at Google Scholar · View at Scopus
26. M. V. Sofroniew, “Molecular dissection of reactive astrogliosis and glial scar formation,” Trends in Neurosciences, vol. 32, no. 12, pp. 638–647, 2009. View at Publisher · View at Google Scholar · View at Scopus
27. M. Eddelston and L. Mucke, “Molecular profile of reactive astrocytes—implications for their role in neurologic disease,” Neuroscience, vol. 54, no. 1, pp. 15–36, 1993. View at Publisher · View at Google Scholar · View at Scopus
28. J. W. Fawcett and R. A. Asher, “The glial scar and central nervous system repair,” Brain Research Bulletin, vol. 49, no. 6, pp. 377–391, 1999. View at Publisher · View at Google Scholar · View at Scopus
29. T. G. Bush, N. Puvanachandra, C. H. Horner et al., “Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice,” Neuron, vol. 23, no. 2, pp. 297–308, 1999. View at Publisher · View at Google Scholar · View at Scopus
30. M. T. Fitch and J. Silver, “CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure,” Experimental Neurology, vol. 209, no. 2, pp. 294–301, 2008. View at Publisher · View at Google Scholar · View at Scopus
31. J. Silver and J. H. Miller, “Regeneration beyond the glial scar,” Nature Reviews Neuroscience, vol. 5, no. 2, pp. 146–156, 2004. View at Scopus
32. V. R. King, A. Alovskaya, D. Y. T. Wei, R. A. Brown, and J. V. Priestley, “The use of injectable forms of fibrin and fibronectin to support axonal ingrowth after spinal cord injury,” Biomaterials, vol. 31, no. 15, pp. 4447–4456, 2010. View at Publisher · View at Google Scholar · View at Scopus
33. P. J. Johnson, S. R. Parker, and S. E. Sakiyama-Elbert, “Fibrin-based tissue engineering scaffolds enhance neural fiber sprouting and delay the accumulation of reactive astrocytes at the lesion in a subacute model of spinal cord injury,” Journal of Biomedical Materials Research A, vol. 92, no. 1, pp. 152–163, 2010. View at Publisher · View at Google Scholar · View at Scopus
34. S. Yoshii, S. Ito, M. Shima, A. Taniguchi, and M. Akagi, “Functional restoration of rabbit spinal cord using collagen-filament scaffold,” Journal of Tissue Engineering and Regenerative Medicine, vol. 3, no. 1, pp. 19–25, 2009. View at Publisher · View at Google Scholar · View at Scopus
35. M. Firouzi, P. Moshayedi, H. Saberi et al., “Transplantation of Schwann cells to subarachnoid space induces repair in contused rat spinal cord,” Neuroscience Letters, vol. 402, no. 1-2, pp. 66–70, 2006. View at Publisher · View at Google Scholar · View at Scopus
36. T. Takami, M. Oudega, M. L. Bates, P. M. Wood, N. Kleitman, and M. B. Bunge, “Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord,” Journal of Neuroscience, vol. 22, no. 15, pp. 6670–6681, 2002. View at Scopus
37. X. M. Xu, A. Chen, V. Guénard, N. Kleitman, and M. B. Bunge, “Bridging Schwann cell transplants promote axonal regeneration from both the rostral and caudal stumps of transected adult rat spinal cord,” Brain Cell Biology, vol. 26, no. 1, pp. 1–16, 1997. View at Scopus
38. H. S. Keirstead, G. Nistor, G. Bernal et al., “Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury,” Journal of Neuroscience, vol. 25, no. 19, pp. 4694–4705, 2005. View at Publisher · View at Google Scholar · View at Scopus
39. J. W. Mcdonald, X. Z. Liu, Y. Qu et al., “Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord,” Nature Medicine, vol. 5, no. 12, pp. 1410–1412, 1999. View at Publisher · View at Google Scholar · View at Scopus
40. M. Chopp, X. H. Zhang, Y. Li et al., “Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation,” NeuroReport, vol. 11, no. 13, pp. 3001–3005, 2000. View at Scopus
41. C. P. Hofstetter, E. J. Schwarz, D. Hess et al., “Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 4, pp. 2199–2204, 2002. View at Publisher · View at Google Scholar · View at Scopus
42. S. Wu, Y. Suzuki, Y. Ejiri et al., “Bone marrow stromal cells enhance differentiation of cocultured neurosphere cells and promote regeneration of injured spinal cord,” Journal of Neuroscience Research, vol. 72, no. 3, pp. 343–351, 2003. View at Publisher · View at Google Scholar · View at Scopus
43. Y. Li, P. M. Field, and G. Raisman, “Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells,” Science, vol. 277, no. 5334, pp. 2000–2002, 1997. View at Publisher · View at Google Scholar · View at Scopus
44. A. Ramón-Cueto, M. I. Cordero, F. F. Santos-Benito, and J. Avila, “Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia,” Neuron, vol. 25, no. 2, pp. 425–435, 2000. View at Scopus
45. A. Ramón-Cueto, G. W. Plant, J. Avila, and M. B. Bunge, “Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants,” Journal of Neuroscience, vol. 18, no. 10, pp. 3803–3815, 1998. View at Scopus
46. W. F. Blakemore, “Remyelination by Schwann cells of axons demyelinated by intraspinal injection of 6 aminonicotinamide in the rat,” Journal of Neurocytology, vol. 4, no. 6, pp. 745–757, 1975. View at Scopus
47. W. F. Blakemore, “Invasion of Schwann cells into the spinal cord of the rat following local injections of lysolecithin,” Neuropathology and Applied Neurobiology, vol. 2, no. 1, pp. 21–39, 1976. View at Scopus
48. A. Pinzon, B. Calancie, M. Oudega, and B. R. Noga E, “Conduction of impulses by axons regenerated in a Schwann cell graft in the transected adult rat thoracic spinal cord,” Journal of Neuroscience Research, vol. 64, no. 5, pp. 533–541, 2001. View at Publisher · View at Google Scholar · View at Scopus
49. B. E. Reubinoff, M. F. Pera, C. Y. Fong, A. Trounson, and A. Bongso, “Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro,” Nature Biotechnology, vol. 18, no. 4, pp. 399–404, 2000. View at Publisher · View at Google Scholar · View at Scopus
50. J. A. Thomson, “Embryonic stem cell lines derived from human blastocysts,” Science, vol. 282, no. 5391, pp. 1145–1147, 1998. View at Scopus
51. S. Liu, Y. Qu, T. J. Stewart et al., “Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 11, pp. 6126–6131, 2000. View at Publisher · View at Google Scholar · View at Scopus
52. S. Yamanaka, “A Fresh Look at iPS Cells,” Cell, vol. 137, no. 1, pp. 13–17, 2009. View at Publisher · View at Google Scholar · View at Scopus
53. O. Tsuji, K. Miura, Y. Okada, et al., “Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, pp. 12704–12709, 2010.
54. S. Nori, Y. Okada, A. Yasuda, et al., “Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, pp. 16825–16830, 2011.
55. M. S. Frankel, “In search of stem cell policy,” Science, vol. 287, no. 5457, p. 1397, 2000. View at Publisher · View at Google Scholar · View at Scopus
56. A. McLaren, “Ethical and social considerations of stem cell research,” Nature, vol. 414, no. 6859, pp. 129–131, 2001. View at Publisher · View at Google Scholar · View at Scopus
57. D. Čížková, J. Rosocha, I. Vanický, S. Jergová, and M. Čížek, “Transplants of human mesenchymal stem cells improve functional recovery after spinal cord injury in the rat,” Cellular and Molecular Neurobiology, vol. 26, no. 7-8, pp. 1167–1180, 2006. View at Publisher · View at Google Scholar · View at Scopus
58. E. Mansilla, G. H. Marin, F. Sturla et al., “Human mesenchymal stem cells are tolerized by mice and improve skin and spinal cord injuries,” Transplantation Proceedings, vol. 37, no. 1, pp. 292–294, 2005. View at Publisher · View at Google Scholar · View at Scopus
59. R. Doucette, “Glial influences on axonal growth in the primary olfactory system,” GLIA, vol. 3, no. 6, pp. 433–449, 1990. View at Scopus
60. B. H. Dobkin, A. Curt, and J. Guest, “Cellular transplants in China: observational study from the largest human experiment in chronic spinal cord injury,” Neurorehabilitation and Neural Repair, vol. 20, no. 1, pp. 5–13, 2006. View at Publisher · View at Google Scholar · View at Scopus
61. G. W. Hawryluk, J. Rowland, B. K. Kwon, and M. G. Fehlings, “Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury,” Neurosurgical Focus, vol. 25, no. 5, article E14, 2008. View at Scopus
62. T. Imaizumi, K. L. Lankford, S. G. Waxman, C. A. Greer, and J. D. Kocsis, “Transplanted olfactory ensheathing cells remyelinate and enhance axonal conduction in the demyelinated dorsal columns of the rat spinal cord,” Journal of Neuroscience, vol. 18, no. 16, pp. 6176–6185, 1998. View at Scopus
63. J. G. Boyd, R. Doucette, and M. D. Kawaja, “Defining the role of olfactory ensheathing cells in facilitating axon remyelination following damage to the spinal cord,” FASEB Journal, vol. 19, no. 7, pp. 694–703, 2005. View at Publisher · View at Google Scholar · View at Scopus
64. M. H. Tuszynski, L. Thal, M. Pay et al., “A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease,” Nature Medicine, vol. 11, no. 5, pp. 551–555, 2005. View at Publisher · View at Google Scholar · View at Scopus
65. L. R. Zhao, W. M. Duan, M. Reyes, C. D. Keene, C. M. Verfaillie, and W. C. Low, “Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats,” Experimental Neurology, vol. 174, no. 1, pp. 11–20, 2002. View at Publisher · View at Google Scholar · View at Scopus
66. D. A. Houweling, J. T. H. Van Asseldonk, A. J. Lankhorst et al., “Local application of collagen containing brain-derived neurotrophic factor decreases the loss of function after spinal cord injury in the adult rat,” Neuroscience Letters, vol. 251, no. 3, pp. 193–196, 1998. View at Publisher · View at Google Scholar · View at Scopus
67. D. M. McTigue, P. J. Horner, B. T. Stokes, and F. H. Gage, “Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord,” Journal of Neuroscience, vol. 18, no. 14, pp. 5354–5365, 1998. View at Scopus
68. Y. Liu, D. Kim, B. T. Himes et al., “Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function,” Journal of Neuroscience, vol. 19, no. 11, pp. 4370–4387, 1999. View at Scopus
69. J. Namiki, A. Kojima, and C. H. Tator, “Effect of brain-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 on functional recovery and regeneration after spinal cord injury in adult rats,” Journal of Neurotrauma, vol. 17, no. 12, pp. 1219–1231, 2000. View at Scopus
70. J. H. Brock, E. S. Rosenzweig, A. Blesch et al., “Local and remote growth factor effects after primate spinal cord injury,” Journal of Neuroscience, vol. 30, no. 29, pp. 9728–9737, 2010. View at Publisher · View at Google Scholar · View at Scopus
71. C. A. Tobias, J. S. Shumsky, M. Shibata et al., “Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration,” Experimental Neurology, vol. 184, no. 1, pp. 97–113, 2003. View at Publisher · View at Google Scholar · View at Scopus
72. B. K. Kwon, J. Liu, C. Messerer et al., “Survival and regeneration of rubrospinal neurons 1 year after spinal cord injury,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 5, pp. 3246–3251, 2002. View at Publisher · View at Google Scholar · View at Scopus
73. T. T. Lee, B. A. Green, W. D. Dietrich, and R. P. Yezierski, “Neuroprotective effects of basic fibroblast growth factor following spinal cord contusion injury in the rat,” Journal of Neurotrauma, vol. 16, no. 5, pp. 347–356, 1999. View at Scopus
74. P. Lu, L. L. Jones, and M. H. Tuszynski, “Axon regeneration through scars and into sites of chronic spinal cord injury,” Experimental Neurology, vol. 203, no. 1, pp. 8–21, 2007. View at Publisher · View at Google Scholar · View at Scopus
75. A. Blesch and M. H. Tuszynski, “Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination,” Journal of Comparative Neurology, vol. 467, no. 3, pp. 403–417, 2003. View at Publisher · View at Google Scholar · View at Scopus
76. A. G. Rabchevsky, I. Fugaccia, A. Fletcher-Turner, D. A. Blades, M. P. Mattson, and S. W. Scheff, “Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following moderate spinal cord injury,” Journal of Neurotrauma, vol. 16, no. 9, pp. 817–830, 1999. View at Scopus
77. A. G. Rabchevsky, I. Fugaccia, A. F. Turner, D. A. Blades, M. P. Mattson, and S. W. Scheff, “Basic fibroblast growth factor (bFGF) enhances functional recovery following severe spinal cord injury to the rat,” Experimental Neurology, vol. 164, no. 2, pp. 280–291, 2000. View at Publisher · View at Google Scholar · View at Scopus
78. R. Grill, K. Murai, A. Blesch, F. H. Gage, and M. H. Tuszynski, “Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury,” The Journal of Neuroscience, vol. 17, no. 14, pp. 5560–5572, 1997.
79. M. H. Tuszynski, R. Grill, L. L. Jones et al., “NT-3 gene delivery elicits growth of chronically injured corticospinal axons and modestly improves functional deficits after chronic scar resection,” Experimental Neurology, vol. 181, no. 1, pp. 47–56, 2003. View at Publisher · View at Google Scholar · View at Scopus
80. X. Cao and M. S. Shoichet, “Defining the concentration gradient of nerve growth factor for guided neurite outgrowth,” Neuroscience, vol. 103, no. 3, pp. 831–840, 2001. View at Publisher · View at Google Scholar · View at Scopus
81. T. A. Kapur and M. S. Shoichet, “Immobilized concentration gradients of nerve growth factor guide neurite outgrowth,” Journal of Biomedical Materials Research A, vol. 68, no. 2, pp. 235–243, 2004. View at Scopus
82. K. Moore, M. Macsween, and M. Shoichet, “Immobilized concentration gradients of neurotrophic factors guide neurite outgrowth of primary neurons in macroporous scaffolds,” Tissue Engineering, vol. 12, no. 2, pp. 267–278, 2006. View at Publisher · View at Google Scholar · View at Scopus
83. C. L. Dou and J. M. Levine, “Inhibition of neurite growth by the NG2 chondroitin sulfate proteoglycan,” Journal of Neuroscience, vol. 14, no. 12, pp. 7616–7628, 1994. View at Scopus
84. L. McKerracher, S. David, D. L. Jackson, V. Kottis, R. J. Dunn, and P. E. Braun, “Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth,” Neuron, vol. 13, no. 4, pp. 805–811, 1994. View at Scopus
85. G. Mukhopadhyay, P. Doherty, F. S. Walsh, P. R. Crocker, and M. T. Filbin, “A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration,” Neuron, vol. 13, no. 3, pp. 757–767, 1994. View at Publisher · View at Google Scholar · View at Scopus
86. B. P. Liu, A. Fournier, T. GrandPre, and S. M. Strittmatter, “Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor,” Science, vol. 297, no. 5584, pp. 1190–1193, 2002. View at Publisher · View at Google Scholar · View at Scopus
87. A. E. Fournier, T. GrandPre, and S. M. Strittmatter, “Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration,” Nature, vol. 409, no. 6818, pp. 341–346, 2001. View at Publisher · View at Google Scholar · View at Scopus
88. M. S. Chen, A. B. Huber, M. E. D. van der Haar et al., “Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1,” Nature, vol. 403, no. 6768, pp. 434–439, 2000. View at Publisher · View at Google Scholar · View at Scopus
89. T. GrandPre, F. Nakamura, T. Vartanlan, and S. M. Strittmatter, “Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein,” Nature, vol. 403, no. 6768, pp. 439–444, 2000. View at Publisher · View at Google Scholar · View at Scopus
90. R. Prinjha, S. E. Moore, M. Vinson et al., “Inhibitor of neurite outgrowth in humans,” Nature, vol. 403, no. 6768, pp. 383–384, 2000. View at Publisher · View at Google Scholar · View at Scopus
91. K. C. Wang, V. Koprivica, J. A. Kim et al., “Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth,” Nature, vol. 417, no. 6892, pp. 941–944, 2002. View at Publisher · View at Google Scholar · View at Scopus
92. S. M. Curristin, A. Cao, W. B. Stewart et al., “Disrupted synaptic development in the hypoxic newborn brain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 24, pp. 15729–15734, 2002. View at Publisher · View at Google Scholar · View at Scopus
93. L. L. Jones, Y. Yamaguchi, W. B. Stallcup, and M. H. Tuszynski, “NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors,” Journal of Neuroscience, vol. 22, no. 7, pp. 2792–2803, 2002. View at Scopus
94. M. Domeniconi, Z. Cao, T. Spencer et al., “Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth,” Neuron, vol. 35, no. 2, pp. 283–290, 2002. View at Publisher · View at Google Scholar · View at Scopus
95. J. Qiu, D. Cai, and M.T. Filbin, “Glial inhibition of nerve regeneration in the mature mammalian CNS,” Glia, vol. 29, pp. 166–174, 2000.
96. M. E. Schwab and D. Bartholdi, “Degeneration and regeneration of axons in the lesioned spinal cord,” Physiological Reviews, vol. 76, no. 2, pp. 319–370, 1996. View at Scopus
97. S. Li, B. P. Liu, S. Budel et al., “Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury,” Journal of Neuroscience, vol. 24, no. 46, pp. 10511–10520, 2004. View at Publisher · View at Google Scholar · View at Scopus
98. M. E. Schwab, “Nogo and axon regeneration,” Current Opinion in Neurobiology, vol. 14, no. 1, pp. 118–124, 2004. View at Publisher · View at Google Scholar · View at Scopus
99. L. Schnell and M. E. Schwab, “Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors,” Nature, vol. 343, no. 6255, pp. 269–272, 1990. View at Publisher · View at Google Scholar · View at Scopus
100. L. Schnell and M. E. Schwab, “Sprouting and regeneration of lesioned corticospinal tract fibres in the adult rat spinal cord,” European Journal of Neuroscience, vol. 5, no. 9, pp. 1156–1171, 1993. View at Scopus
101. M. Simonen, V. Pedersen, O. Weinmann et al., “Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury,” Neuron, vol. 38, no. 2, pp. 201–211, 2003. View at Publisher · View at Google Scholar · View at Scopus
102. D. Montag, K. P. Giese, U. Bartsch et al., “Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin,” Neuron, vol. 13, no. 1, pp. 229–246, 1994. View at Publisher · View at Google Scholar · View at Scopus
103. M. Li, A. Shibata, C. Li, et al., “Myelin-associated glycoprotein inhibits neurite/axon growth and causes growth cone collapse,” Journal of Neuroscience Research, vol. 46, pp. 404–414, 1996.
104. P. Dergham, B. Ellezam, C. Essagian, H. Avedissian, W. D. Lubell, and L. McKerracher, “Rho signaling pathway targeted to promote spinal cord repair,” Journal of Neuroscience, vol. 22, no. 15, pp. 6570–6577, 2002. View at Scopus
105. A. E. Fournier, B. T. Takizawa, and S. M. Strittmatter, “Rho kinase inhibition enhances axonal regeneration in the injured CNS,” Journal of Neuroscience, vol. 23, no. 4, pp. 1416–1423, 2003. View at Scopus
106. S. Neumann, F. Bradke, M. Tessier-Lavigne, and A. I. Basbaum, “Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation,” Neuron, vol. 34, no. 6, pp. 885–893, 2002. View at Publisher · View at Google Scholar · View at Scopus
107. J. Qiu, D. Cai, H. Dai et al., “Spinal axon regeneration induced by elevation of cyclic AMP,” Neuron, vol. 34, no. 6, pp. 895–903, 2002. View at Publisher · View at Google Scholar · View at Scopus
108. K. L. Golden, D. D. Pearse, B. Blits et al., “Transduced Schwann cells promote axon growth and myelination after spinal cord injury,” Experimental Neurology, vol. 207, no. 2, pp. 203–217, 2007. View at Publisher · View at Google Scholar · View at Scopus
109. N. Weidner, A. Blesch, R. J. Grill, and M. H. Tuszynski, “Nerve growth factor-hypersecreting schwann cell grafts augment and guide spinal cord axonal growth and remyelinate central nervous system axons in a phenotypically appropriate manner that correlates with expression of L1,” The Journal of Comparative Neurology, vol. 413, pp. 495–506, 1999.
110. X. M. Xu, V. Guenard, N. Kleitman, P. Aebischer, and M. B. Bunge, “A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord,” Experimental Neurology, vol. 134, no. 2, pp. 261–272, 1995. View at Publisher · View at Google Scholar · View at Scopus
111. Y. B. Deng, Y. Liu, W. B. Zhu et al., “The co-transplantation of human bone marrow stromal cells and embryo olfactory ensheathing cells as a new approach to treat spinal cord injury in a rat model,” Cytotherapy, vol. 10, no. 6, pp. 551–564, 2008. View at Publisher · View at Google Scholar · View at Scopus
112. D. D. Pearse, A. R. Sanchez, F. C. Pereira et al., “Transplantation of Schwann cells and/or olfactory ensheathing glia into the contused spinal cord: survival, migration, axon association, and functional recovery,” GLIA, vol. 55, no. 9, pp. 976–1000, 2007. View at Publisher · View at Google Scholar · View at Scopus
113. Y. S. Zeng, Y. Ding, L. Z. Wu et al., “Co-transplantation of Schwann cells promotes the survival and differentiation of neural stem cells transplanted into the injured spinal cord,” Developmental Neuroscience, vol. 27, no. 1, pp. 20–26, 2005. View at Publisher · View at Google Scholar · View at Scopus
114. P. Lu, L. L. Jones, and M. H. Tuszynski, “BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury,” Experimental Neurology, vol. 191, no. 2, pp. 344–360, 2005. View at Publisher · View at Google Scholar · View at Scopus
115. Q. Han, W. Sun, H. Lin et al., “Linear ordered collagen scaffolds loaded with collagen-binding brain-derived neurotrophic factor improve the recovery of spinal cord injury in rats,” Tissue Engineering A, vol. 15, no. 10, pp. 2927–2935, 2009. View at Publisher · View at Google Scholar · View at Scopus
116. S. Stokols and M. H. Tuszynski, “Freeze-dried agarose scaffolds with uniaxial channels stimulate and guide linear axonal growth following spinal cord injury,” Biomaterials, vol. 27, no. 3, pp. 443–451, 2006. View at Publisher · View at Google Scholar · View at Scopus
117. S. J. Taylor, J. W. McDonald, and S. E. Sakiyama-Elbert, “Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury,” Journal of Controlled Release, vol. 98, no. 2, pp. 281–294, 2004. View at Publisher · View at Google Scholar · View at Scopus
118. S. J. Taylor, E. S. Rosenzweig, J. W. McDonald, and S. E. Sakiyama-Elbert, “Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury,” Journal of Controlled Release, vol. 113, no. 3, pp. 226–235, 2006. View at Publisher · View at Google Scholar · View at Scopus
119. H. M. Tuinstra, M. O. Aviles, S. Shin, et al., “Multifunctional, multichannel bridges that deliver neurotrophin encoding lentivirus for regeneration following spinal cord injury,” Biomaterials, vol. 33, pp. 1618–1626, 2012.
120. H. Itosaka, S. Kuroda, H. Shichinohe et al., “Fibrin matrix provides a suitable scaffold for bone marrow stromal cells transplanted into injured spinal cord: a novel material for CNS tissue engineering,” Neuropathology, vol. 29, no. 3, pp. 248–257, 2009. View at Publisher · View at Google Scholar · View at Scopus
121. Y. D. Teng, E. B. Lavik, X. Qu, et al., “Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, pp. 3024–3029, 2002.
122. P. J. Johnson, S. R. Parker, and S. E. Sakiyama-Elbert, “Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury,” Biotechnology and Bioengineering, vol. 104, no. 6, pp. 1207–1214, 2009. View at Publisher · View at Google Scholar · View at Scopus
123. P. D. Storer, D. Dolbeare, and J. D. Houle, “Treatment of chronically injured spinal cord with neurotrophic factors stimulates βII-tubulin and GAP-43 expression in rubrospinal tract neurons,” Journal of Neuroscience Research, vol. 74, no. 4, pp. 502–511, 2003. View at Publisher · View at Google Scholar · View at Scopus